SEC Form 4 · accession 0001162194-15-000046
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert C Jones
Officer — EVP, RESEARCH & DEVELOPMENT
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 8:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2015 | M | 3,000 | $14.60 | A | 3,947 | D | |
| Common StockF2 | Mar 2, 2015 | S | 1,500 | $43.4127 | D | 2,447 | D | |
| Common StockF3 | Mar 2, 2015 | S | 1,500 | $44.147 | D | 947 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $14.60 | Mar 2, 2015 | M | 3,000 | D | — | May 17, 2021 | Common Stock | 3,000 | 5,701 | D |
Explanation of responses
- F1The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2014 as amended on December 12, 2014.
- F2The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $42.94 to $43.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $43.81 to $44.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F41/48th of the shares subject to the Option vested on June 18, 2011 and 1/48th of the shares subject to the Option vest each month thereafter, such that the Option will be fully vested on May 18, 2015.